MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Limited human safety data Animal toxicology shows wide therapeutic window Injection-site reactions reported anecdotally Known interactions Anticoagulants (theoretical, due to angiogenic activity unstudied) Contraindications Active malignancy (theoretical, due to angiogenic mechanism) Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Placed on FDA Category 2 of the 503A bulks list (September 2023 update), barring compounding pharmacies from preparing it under section 503A
O'Brien LE, Tang K, Kats ES, Schutz-Geschwender A, Lipschutz JH, Mostov KE (July 2004)
Sn phm c m t l cha cc thnh phn nh glutathione, cc cht h tr gan v h min dch, cng vi mt s dng cht c th c tc dng h tr sc khe ln da
Journal of the American Society of Nephrology, 31 (3), 456
The OCMSs and 3DPC materials were assembled as positive and negative electrodes in a potassium ion capacitor (PIC) device